Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: LoLoLoLita who wrote (4473)	1/12/1998 2:26:00 PM
From: Gene Voss	Read Replies (2) \| Respond to of 23519

Araq: The HVSF claim is a common patent challenge especially if you may be infringing.Vivus is very aware of the case and is taking steps to respond. This is really a nonevent since court cases like this could take longer than the patent lasts.HVSF"S life depends on invalidating the patent since they are obviously infringing .Vivus has licensed this patent and will fight to protect it.If you are afraid that this challenge will significantly affect Vivus your fears are unfounded.The patent has been in place for 10 years so the odds are against HVSF"s claim.Vivus would never have licensed this without a thorough knowledge of the facts and some high powered opinions from the best patent attorney's.Any patent is subject to challenge but my opinion is that HVSF has a relatively difficult battle on their hands. GV